| |
| |
|
| Insider
Information: |
Albers Jeffrey W. |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
180,202 |
|
|
Indirect Shares
|
34,360 |
|
|
| Direct
Value |
$19,076,162 |
|
|
|
Indirect Value
|
$20,640 |
|
|
| Total
Shares |
214,562 |
|
|
| Total
Value |
$19,096,802 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 151.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Blueprint Medicines Corp |
BPMC |
|
2024-03-20 |
176,050 |
|
0 |
Premium* |
|
|
Dianthus Therapeutics Ord Shs |
DNTH |
Director |
2018-06-25 |
4,152 |
2018-06-25 |
0 |
Premium* |
|
|
Aeglea Biotherapeutics, Inc. |
AGLE |
|
2023-11-24 |
0 |
2023-11-24 |
34,360 |
Premium* |
|
|
Kymera Therapeutics, Inc. |
KYMR |
|
2024-02-21 |
0 |
2024-01-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2024-03-20 |
4 |
AS |
$85.22 |
$2,188,265 |
D/D |
(25,073) |
176,050 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2024-03-20 |
4 |
OE |
$1.87 |
$178,287 |
D/D |
25,073 |
201,123 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2024-03-07 |
4 |
S |
$90.69 |
$1,000,583 |
D/D |
(11,033) |
165,017 |
0 |
% |
|
| KYMR |
Kymera Therapeutics, Inc. |
|
– • – |
2024-02-21 |
4 |
AS |
$39.05 |
$171,227 |
D/D |
(4,385) |
0 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
|
– • – |
2024-02-21 |
4 |
OE |
$10.34 |
$45,341 |
D/D |
4,385 |
4,385 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
|
– • – |
2024-02-20 |
4 |
OE |
$10.34 |
$6,359 |
D/D |
615 |
615 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
|
– • – |
2024-02-20 |
4 |
AS |
$39.07 |
$24,031 |
D/D |
(615) |
0 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2024-01-25 |
4 |
AS |
$81.16 |
$2,047,800 |
D/D |
(25,000) |
176,050 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2024-01-25 |
4 |
OE |
$1.87 |
$178,150 |
D/D |
25,000 |
201,050 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
|
– • – |
2024-01-23 |
4 |
OE |
$10.34 |
$103,400 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
|
– • – |
2024-01-23 |
4 |
AS |
$30.05 |
$300,470 |
D/D |
(10,000) |
0 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-12-11 |
4 |
OE |
$36.05 |
$180,250 |
D/D |
5,000 |
181,050 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-12-11 |
4 |
AS |
$79.07 |
$395,350 |
D/D |
(5,000) |
176,050 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-11-30 |
4 |
AS |
$70.55 |
$352,750 |
D/D |
(5,000) |
176,050 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-11-30 |
4 |
OE |
$36.05 |
$180,250 |
D/D |
5,000 |
181,050 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-11-24 |
4 |
AS |
$67.25 |
$1,012,690 |
D/D |
(15,000) |
176,050 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-11-24 |
4 |
OE |
$1.87 |
$28,050 |
D/D |
15,000 |
191,050 |
0 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
|
– • – |
2023-11-24 |
4/A |
A |
$0.00 |
$0 |
I/I |
34,360 |
34,360 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-09-28 |
4 |
AS |
$50.17 |
$346,073 |
D/D |
(6,898) |
176,050 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-09-28 |
4 |
OE |
$1.87 |
$12,899 |
D/D |
6,898 |
182,948 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-09-27 |
4 |
AS |
$48.84 |
$897,957 |
D/D |
(18,102) |
176,050 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-09-27 |
4 |
OE |
$1.87 |
$33,851 |
D/D |
18,102 |
194,152 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-08-25 |
4 |
AS |
$50.16 |
$501,600 |
D/D |
(10,000) |
176,050 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-08-25 |
4 |
OE |
$1.87 |
$18,700 |
D/D |
10,000 |
186,050 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-08-24 |
4 |
AS |
$49.57 |
$743,550 |
D/D |
(15,000) |
176,050 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
